Synthesis of chalcones with anticancer activities

Area of Science:

• Medicinal Chemistry
• Cancer Biology
• Molecular Pharmacology

Background:

• Chalcones are a class of natural products with diverse biological activities.
• Developing novel cytotoxic agents for cancer therapy remains a significant challenge.

Purpose of the Study:

• To synthesize and evaluate the in vitro cytotoxicity of novel chalcone derivatives.
• To investigate the mechanism of action of potent chalcone compounds in human breast cancer cells (MCF-7).

Main Methods:

• Synthesis of chalcone compounds.
• In vitro cytotoxicity assays against multiple human cancer cell lines (MCF-7, A549, PC3, HT-29) and a normal liver cell line (WRL-68).
• Apoptosis induction studies using multiparameter assays, caspase activity measurements (caspase-3/7, -8, -9), and reactive oxygen species (ROS) level determination.

Main Results:

• Several synthesized chalcones exhibited significant in vitro cytotoxicity.
• Four selected compounds (1, 5, 23, and 25) demonstrated potent cytotoxic effects against MCF-7 cells.
• These compounds induced apoptosis in MCF-7 cells, evidenced by increased caspase activities and a 1.3-fold rise in ROS levels.
• Apoptosis was mediated through both intrinsic and extrinsic pathways.

Conclusions:

• The synthesized chalcones are promising cytotoxic agents against human breast cancer cells.
• The mechanism of action involves ROS generation, leading to apoptosis via intrinsic and extrinsic pathways.
• These findings support the potential development of these chalcones as novel anti-cancer therapeutics.